Lin, Shan
Schneider, Constanze
Su, Angela H.
Alexe, Gabriela http://orcid.org/0000-0002-5668-6297
Root, David E.
Stegmaier, Kimberly http://orcid.org/0000-0003-0218-7895
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA210030, CA263161)
Helen Gurley Brown Foundation, The Selig Family Fund for Pediatric Cancer Research
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Leukemia and Lymphoma Society
Deutsche Forschungsgemeinschaft (SCHN 1622/1-1)
Article History
Received: 26 September 2023
Revised: 30 January 2024
Accepted: 7 February 2024
First Online: 16 February 2024
Competing interests
: KS receives grant funding from the DFCI/Novartis Drug Discovery Program and from KronosBio, is a member of the SAB and has stock options with Auron Therapeutics and has consulted for AstraZeneca on topics unrelated to this work. D.E.R. receives research funding from members of the Functional Genomics Consortium (Abbvie, BMS, Jannsen, Merck, Vir), and is a director of Addgene, Inc.